Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: Secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial

  • Alfred Callahan
  • , Pierre Amarenco
  • , Larry B. Goldstein
  • , Henrik Sillesen
  • , Mike Messig
  • , Gregory P. Samsa
  • , Irfan Altafullah
  • , Lucy Y. Ledbetter
  • , Mary J. MacLeod
  • , Russell Scott
  • , Michael Hennerici
  • , Justin A. Zivin
  • , K. Michael A. Welch

Producción científica: Article › revisión exhaustiva

95 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: Secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial'. En conjunto forman una huella única.

Nursing and Health Professions

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience